Studies of structure-activity relations of complement inhibitor compstatin

Athena Soulika, Dimitrios Morikis, Maria Rosa Sarrias, Melinda Roy, Lynn A. Spruce, Arvind Sahu, John D. Lambris

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Compstatin, a 13-mer cyclic peptide, is a novel and promising inhibitor of the activation of the complement system. In our search for a more active analog and better understanding of structure-functions relations, we designed a phage-displayed random peptide library based on previous knowledge of structure activity relations, in which seven amino acids deemed necessary for structure and activity were kept fixed while the remaining six were optimized. Screening of this library against C3 identified four binding clones. Synthetic peptides corresponding to these clones revealed one analog, called acetylated Ile 1Leu/His9Trp/Thr13Gly triple replacement analog of compstatin corresponding to clone 640 (Ac-I1L/H9W/T13G), which was more active than compstatin. This newly identified peptide had 4-fold higher activity when compared with the originally isolated form of compstatin and 1.6-fold higher activity when compared with acetylated compstatin (Ac-compstatin). The structures of Ac-I1L/H9W/T13G and Ac-compstatin were studied by nuclear magnetic resonance, compared with the structure of compstatin, and found to be very similar. The binding of Ac-I1L/H9W/T13G and the equally active acetylated analog with His9Ala replacement (Ac-H9A) to C3 was evaluated by surface plasmon resonance, which suggested similarity in their binding mechanism but difference when compared with Ac-compstatin. Compensatory effects of flexibility outside the β-turn and tryptophan ring stacking may be responsible for the measured activity increase in Ac-I1L/H9W/T13G and acetylated analog with His9Ala replacement and the variability in binding mechanism compared with Ac-compstatin. These data demonstrate that tryptophan is a key amino acid for activity. Finally, the significance of the N-terminal acetylation was examined and it was found that the hydrophobic cluster at the linked termini of compstatin is essential for binding to C3 and for activity.

Original languageEnglish (US)
Pages (from-to)1881-1890
Number of pages10
JournalJournal of Immunology
Volume171
Issue number4
StatePublished - Aug 15 2003
Externally publishedYes

Fingerprint

Complement Inactivating Agents
Clone Cells
Tryptophan
compstatin
Amino Acids
Peptide Library
Cyclic Peptides
Peptides
Surface Plasmon Resonance
Complement Activation

ASJC Scopus subject areas

  • Immunology

Cite this

Soulika, A., Morikis, D., Sarrias, M. R., Roy, M., Spruce, L. A., Sahu, A., & Lambris, J. D. (2003). Studies of structure-activity relations of complement inhibitor compstatin. Journal of Immunology, 171(4), 1881-1890.

Studies of structure-activity relations of complement inhibitor compstatin. / Soulika, Athena; Morikis, Dimitrios; Sarrias, Maria Rosa; Roy, Melinda; Spruce, Lynn A.; Sahu, Arvind; Lambris, John D.

In: Journal of Immunology, Vol. 171, No. 4, 15.08.2003, p. 1881-1890.

Research output: Contribution to journalArticle

Soulika, A, Morikis, D, Sarrias, MR, Roy, M, Spruce, LA, Sahu, A & Lambris, JD 2003, 'Studies of structure-activity relations of complement inhibitor compstatin', Journal of Immunology, vol. 171, no. 4, pp. 1881-1890.
Soulika A, Morikis D, Sarrias MR, Roy M, Spruce LA, Sahu A et al. Studies of structure-activity relations of complement inhibitor compstatin. Journal of Immunology. 2003 Aug 15;171(4):1881-1890.
Soulika, Athena ; Morikis, Dimitrios ; Sarrias, Maria Rosa ; Roy, Melinda ; Spruce, Lynn A. ; Sahu, Arvind ; Lambris, John D. / Studies of structure-activity relations of complement inhibitor compstatin. In: Journal of Immunology. 2003 ; Vol. 171, No. 4. pp. 1881-1890.
@article{3f2b1f49b2684cf9919aaf8acba0d5fe,
title = "Studies of structure-activity relations of complement inhibitor compstatin",
abstract = "Compstatin, a 13-mer cyclic peptide, is a novel and promising inhibitor of the activation of the complement system. In our search for a more active analog and better understanding of structure-functions relations, we designed a phage-displayed random peptide library based on previous knowledge of structure activity relations, in which seven amino acids deemed necessary for structure and activity were kept fixed while the remaining six were optimized. Screening of this library against C3 identified four binding clones. Synthetic peptides corresponding to these clones revealed one analog, called acetylated Ile 1Leu/His9Trp/Thr13Gly triple replacement analog of compstatin corresponding to clone 640 (Ac-I1L/H9W/T13G), which was more active than compstatin. This newly identified peptide had 4-fold higher activity when compared with the originally isolated form of compstatin and 1.6-fold higher activity when compared with acetylated compstatin (Ac-compstatin). The structures of Ac-I1L/H9W/T13G and Ac-compstatin were studied by nuclear magnetic resonance, compared with the structure of compstatin, and found to be very similar. The binding of Ac-I1L/H9W/T13G and the equally active acetylated analog with His9Ala replacement (Ac-H9A) to C3 was evaluated by surface plasmon resonance, which suggested similarity in their binding mechanism but difference when compared with Ac-compstatin. Compensatory effects of flexibility outside the β-turn and tryptophan ring stacking may be responsible for the measured activity increase in Ac-I1L/H9W/T13G and acetylated analog with His9Ala replacement and the variability in binding mechanism compared with Ac-compstatin. These data demonstrate that tryptophan is a key amino acid for activity. Finally, the significance of the N-terminal acetylation was examined and it was found that the hydrophobic cluster at the linked termini of compstatin is essential for binding to C3 and for activity.",
author = "Athena Soulika and Dimitrios Morikis and Sarrias, {Maria Rosa} and Melinda Roy and Spruce, {Lynn A.} and Arvind Sahu and Lambris, {John D.}",
year = "2003",
month = "8",
day = "15",
language = "English (US)",
volume = "171",
pages = "1881--1890",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "4",

}

TY - JOUR

T1 - Studies of structure-activity relations of complement inhibitor compstatin

AU - Soulika, Athena

AU - Morikis, Dimitrios

AU - Sarrias, Maria Rosa

AU - Roy, Melinda

AU - Spruce, Lynn A.

AU - Sahu, Arvind

AU - Lambris, John D.

PY - 2003/8/15

Y1 - 2003/8/15

N2 - Compstatin, a 13-mer cyclic peptide, is a novel and promising inhibitor of the activation of the complement system. In our search for a more active analog and better understanding of structure-functions relations, we designed a phage-displayed random peptide library based on previous knowledge of structure activity relations, in which seven amino acids deemed necessary for structure and activity were kept fixed while the remaining six were optimized. Screening of this library against C3 identified four binding clones. Synthetic peptides corresponding to these clones revealed one analog, called acetylated Ile 1Leu/His9Trp/Thr13Gly triple replacement analog of compstatin corresponding to clone 640 (Ac-I1L/H9W/T13G), which was more active than compstatin. This newly identified peptide had 4-fold higher activity when compared with the originally isolated form of compstatin and 1.6-fold higher activity when compared with acetylated compstatin (Ac-compstatin). The structures of Ac-I1L/H9W/T13G and Ac-compstatin were studied by nuclear magnetic resonance, compared with the structure of compstatin, and found to be very similar. The binding of Ac-I1L/H9W/T13G and the equally active acetylated analog with His9Ala replacement (Ac-H9A) to C3 was evaluated by surface plasmon resonance, which suggested similarity in their binding mechanism but difference when compared with Ac-compstatin. Compensatory effects of flexibility outside the β-turn and tryptophan ring stacking may be responsible for the measured activity increase in Ac-I1L/H9W/T13G and acetylated analog with His9Ala replacement and the variability in binding mechanism compared with Ac-compstatin. These data demonstrate that tryptophan is a key amino acid for activity. Finally, the significance of the N-terminal acetylation was examined and it was found that the hydrophobic cluster at the linked termini of compstatin is essential for binding to C3 and for activity.

AB - Compstatin, a 13-mer cyclic peptide, is a novel and promising inhibitor of the activation of the complement system. In our search for a more active analog and better understanding of structure-functions relations, we designed a phage-displayed random peptide library based on previous knowledge of structure activity relations, in which seven amino acids deemed necessary for structure and activity were kept fixed while the remaining six were optimized. Screening of this library against C3 identified four binding clones. Synthetic peptides corresponding to these clones revealed one analog, called acetylated Ile 1Leu/His9Trp/Thr13Gly triple replacement analog of compstatin corresponding to clone 640 (Ac-I1L/H9W/T13G), which was more active than compstatin. This newly identified peptide had 4-fold higher activity when compared with the originally isolated form of compstatin and 1.6-fold higher activity when compared with acetylated compstatin (Ac-compstatin). The structures of Ac-I1L/H9W/T13G and Ac-compstatin were studied by nuclear magnetic resonance, compared with the structure of compstatin, and found to be very similar. The binding of Ac-I1L/H9W/T13G and the equally active acetylated analog with His9Ala replacement (Ac-H9A) to C3 was evaluated by surface plasmon resonance, which suggested similarity in their binding mechanism but difference when compared with Ac-compstatin. Compensatory effects of flexibility outside the β-turn and tryptophan ring stacking may be responsible for the measured activity increase in Ac-I1L/H9W/T13G and acetylated analog with His9Ala replacement and the variability in binding mechanism compared with Ac-compstatin. These data demonstrate that tryptophan is a key amino acid for activity. Finally, the significance of the N-terminal acetylation was examined and it was found that the hydrophobic cluster at the linked termini of compstatin is essential for binding to C3 and for activity.

UR - http://www.scopus.com/inward/record.url?scp=0041589374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041589374&partnerID=8YFLogxK

M3 - Article

C2 - 12902490

AN - SCOPUS:0041589374

VL - 171

SP - 1881

EP - 1890

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 4

ER -